Clinical implications of microscopic extrathyroidal extension in patients with papillary thyroid carcinoma

淋巴血管侵犯 医学 甲状腺癌 淋巴结转移 淋巴结 转移 甲状腺切除术 甲状腺全切除术 解剖(医学) 病理 内科学 胃肠病学 甲状腺 放射科 癌症
作者
Ji Su Park,Jae Won Chang,Lihua Liu,Seung‐Nam Jung,Bon Seok Koo
出处
期刊:Oral Oncology [Elsevier]
卷期号:72: 183-187 被引量:54
标识
DOI:10.1016/j.oraloncology.2017.02.008
摘要

Extrathyroidal extension (ETE) is a poor prognostic factor in papillary thyroid carcinoma (PTC). However, the impact of the degree of ETE, especially microscopic ETE, has not been well established. The purpose of present study was to compare differences in clinicopathological characteristics and clinical outcomes according to the presence or extent of ETE.Data from 381 patients who underwent total thyroidectomy with/without lymph node (LN) dissection for PTC between 2004 and 2010 were analyzed. Clinicopathological features such as age, gender, LN metastasis, capsular invasion, lymphovascular invasion, and recurrence were compared among three groups divided according to degree of ETE: no ETE (n=144), microscopic ETE (n=191), and macroscopic ETE (n=46).Tumor size, LN metastasis, lymphovascular invasion, extent of surgery, and administration of postoperative radioactive iodine (RAI) were significantly correlated with degree of ETE. Especially, among the patients with a primary tumor size ≤4cm, the patients with microscopic ETE showed more LN metastasis and lymphovascular invasion than those without ETE, whereas less LN metastasis and lymphovascular invasion than those with macroscopic ETE. In addition, the microscopic ETE group had a significantly lower 5-year recurrence free survival (RFS) than the no-ETE group (92.1% vs. 99.3%, p<0.001) and a significantly higher 5-year RFS than the macroscopic ETE group (92.1% vs. 65.2%, p<0.001).The degree of ETE is correlated with clinicopathologic features and tumor recurrence. Patients with microscopic ETE have a poorer clinical outcome than those without ETE, but they showed a better outcome than patients with macroscopic ETE.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
康康完成签到,获得积分10
刚刚
七七完成签到 ,获得积分10
1秒前
huangpeihao发布了新的文献求助10
1秒前
小狗说好运来完成签到 ,获得积分10
2秒前
3秒前
小马甲应助康康采纳,获得10
4秒前
科研通AI6.1应助张文群采纳,获得10
5秒前
郭嘉完成签到,获得积分20
6秒前
hu发布了新的文献求助10
6秒前
科研通AI6.3应助高岩采纳,获得10
7秒前
7秒前
大模型应助科研通管家采纳,获得10
7秒前
8秒前
8秒前
科目三应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
Jasper应助科研通管家采纳,获得10
8秒前
香蕉觅云应助科研通管家采纳,获得10
8秒前
所所应助科研通管家采纳,获得30
8秒前
鲨鱼辣椒应助科研通管家采纳,获得10
8秒前
搜集达人应助科研通管家采纳,获得10
8秒前
9秒前
9秒前
9秒前
充电宝应助科研通管家采纳,获得10
9秒前
9秒前
MOON发布了新的文献求助30
9秒前
李1完成签到,获得积分10
10秒前
2021完成签到 ,获得积分10
10秒前
李富贵儿~完成签到,获得积分10
11秒前
CipherSage应助BaoCure采纳,获得10
11秒前
蓝莓橘子酱应助wzzznh采纳,获得10
12秒前
Waley发布了新的文献求助20
13秒前
hypo发布了新的文献求助10
15秒前
深情安青应助balevc采纳,获得10
15秒前
科研通AI6.3应助JiangXueBa采纳,获得10
15秒前
x的3次方完成签到,获得积分20
15秒前
舒心的宛菡完成签到 ,获得积分10
15秒前
高岩完成签到,获得积分20
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 生物化学 化学工程 物理 计算机科学 复合材料 内科学 催化作用 物理化学 光电子学 电极 冶金 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6023016
求助须知:如何正确求助?哪些是违规求助? 7645959
关于积分的说明 16171105
捐赠科研通 5171318
什么是DOI,文献DOI怎么找? 2767068
邀请新用户注册赠送积分活动 1750461
关于科研通互助平台的介绍 1637029